Welcome to our dedicated page for QT Imaging Holdings SEC filings (Ticker: QTIH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QT Imaging Holdings’ cutting-edge breast and musculoskeletal imaging technology may be radiation-free, but its SEC paperwork certainly isn’t. Clinical-trial updates, FDA clearance timelines, and multi-year R&D commitments are scattered across hundreds of pages—details that can determine the value of every share. If you’ve ever opened a 300-page 10-K and wondered where the pipeline milestones or cash-burn figures hide, you know the challenge.
Stock Titan’s AI solves that problem instantly. Our platform turns a dense QT Imaging Holdings quarterly earnings report 10-Q filing into plain-English insights, flags material events from each 8-K, and pushes QT Imaging Holdings Form 4 insider transactions real-time to your dashboard. Prefer narrative questions? Just ask “understanding QT Imaging Holdings SEC documents with AI” and you’ll see streamlined answers. The system covers every form—10-K, 10-Q, 8-K, S-1, and the all-important QT Imaging Holdings proxy statement executive compensation—with real-time EDGAR feeds and side-by-side historical comparisons.
Why it matters: Investors use these filings to gauge when FDA approvals may hit revenue, track capital raises, and spot QT Imaging Holdings insider trading Form 4 transactions ahead of clinical catalysts. Our AI-powered summaries highlight R&D trends, segment margins, and patent disclosures, offering the QT Imaging Holdings earnings report filing analysis you need without parsing footnotes. Whether you’re confirming an 8-K material events explained alert or diving into a QT Imaging Holdings annual report 10-K simplified, Stock Titan delivers the clarity professionals require—saving hours and surfacing insights that move portfolios.
QT Imaging Holdings (QTIH) reported Q3 results showing higher sales but continued losses. Revenue reached $4,192,101 versus $955,970 a year ago, with gross profit of $1,802,673. Operating loss was $1,652,079 and net loss was $4,557,406. For the nine months, revenue was $10,649,930 and net loss totaled $19,694,921.
Cash and restricted cash were $1,735,400 at quarter‑end, while total liabilities were $21,197,385, resulting in a stockholders’ deficit of $9,076,444. The company completed financings including a senior secured term loan (initially $10.1 million, amended to $15.1 million with Tranche B) and an October 2025 private placement providing gross proceeds of $18,180,655 at $4.50 per share. A 3‑for‑1 reverse stock split became effective October 23, 2025. Customer concentration remained high, with Customer A accounting for 99% of Q3 revenue. Management cites minimum order quantities under U.S. and Saudi Arabia distribution agreements as expected support for future cash flows.
QT Imaging Holdings, Inc. furnished an investor presentation under Item 7.01 (Reg FD). On November 10, 2025, the company posted the presentation to its website and furnished it as Exhibit 99.1 to an 8‑K. The information is being furnished, not filed, is not subject to Section 18 liabilities, and is not incorporated by reference into other filings. The company directs readers to Exhibit 99.1 for forward‑looking statements and related risks.
QT Imaging Holdings, Inc. filed a Form S-1 to register up to 29,336,017 shares of common stock for resale by selling securityholders, to be offered from time to time after effectiveness. The registration covers 2,562,334 already-issued shares and 26,773,683 shares issuable upon warrant exercises, including Five Year Common Warrants (24,442,342 shares), Ten Year Common Warrants (523,286 shares), and Pre-Funded Warrants (1,808,055 shares).
The company will not receive proceeds from sales by selling holders; it may receive cash only if warrants are exercised. The filing details a 3:1 reverse stock split effective October 23, 2025. It also outlines financing events: a senior secured term loan with Lynrock Lake totaling $15,100,000 and a related warrant adjusted to 20,333,623 shares at $1.20 post-split, and three private placements with aggregate gross proceeds of approximately $500,000, $200,000, and $18,180,655. The prospectus warns that large potential resales could pressure the stock price.
QT Imaging Holdings, Inc. (QTIH) announced market effectiveness of a 3:1 reverse stock split on October 24, 2025. The company disclosed the update via a press release titled “QT Imaging 3:1 Reverse Stock Split Market Effective on October 24, 2025,” furnished as Exhibit 99.1.
The notice was provided under Item 8.01 (Other Events) in a current report, with the filing signed by Chief Executive Officer Raluca Dinu.
QT Imaging Holdings, Inc. implemented a reverse stock split of its common stock at a 3:1 ratio. The Certificate of Amendment became effective at 4:01 p.m. Eastern Time on October 23, 2025.
The company’s common stock will begin trading on the OTCQB Venture Market on a reverse split‑adjusted basis on October 24, 2025. Stockholders previously approved a reverse split within a 2:1 to 20:1 range, and the board set the final ratio at 3:1.
QT Imaging Holdings, Inc. announced a reverse stock split of its common stock at a 3:1 ratio. The split will be effective at 4:01 p.m. Eastern Time on October 23, 2025, after which the stock is expected to begin trading on the OTCQB Venture Market on a reverse split–adjusted basis on October 24, 2025. The common stock’s CUSIP will change to 746962307.
Stockholders previously approved a reverse split within a 2:1 to 20:1 range at the August 19, 2025 Annual Meeting, authorizing the board to set the final ratio. The company also disclosed it has submitted an application to relist on the Nasdaq Capital Market and issued a press release on October 20, 2025 detailing these plans.
QT Imaging Holdings disclosed terms of subscription and pre-funded warrants issued in a private placement and related registration rights. The Subscription Warrants include standard adjustments for stock splits and similar events and provide that, in a Fundamental Transaction, holders may receive alternate consideration in the form and proportion offered to common stockholders. The company may, at a holder's option, purchase unexercised portions of Subscription Warrants for cash equal to the Black Scholes value; if the Fundamental Transaction is not within the company's control, holders receive the same form of consideration offered to common stockholders.
The Pre-Funded Warrants are exercisable for 5,424,083 shares of common stock at $0.0001 per share and expire upon full exercise. Under the Registration Rights Agreement entered with purchasers, the company must file a registration statement for resale of registrable securities within 30 days and have it declared effective as promptly as practicable, and in any event within 90 days (or 120 days if the SEC conducts a full review).
FAQ
What is the current stock price of QT Imaging Holdings (QTIH)?
What is the market cap of QT Imaging Holdings (QTIH)?
